Valeant Pharmaceuticals Careers NewsEmployer Directory Featured Listing, Feeds and Subscriptions

The latest Valeant Pharmaceuticals careers news and job posts. Subscribe for daily updates to your inbox, mobile device and/or smartphone.

  Jobs Feed | Subscribe  

**Overview** Valeant Pharmaceuticals International, Inc. is a diverse and decentralized pharmaceutical company that is committed to focusing on our key stakeholders while delivering consistently high performance. Our values provide the ove...
Posted: January 22, 2018, 8:09 am
**Overview** Valeant Pharmaceuticals International, Inc. is a diverse and decentralized pharmaceutical company that is committed to focusing on our key stakeholders while delivering consistently high performance. Our values provide the ove...
Posted: January 20, 2018, 9:45 am
**Overview** Valeant Pharmaceuticals International, Inc. is a diverse pharmaceutical company that is committed to focusing on our key stakeholders while delivering consistently high performance. Our values provide the overall direction for ...
Posted: January 20, 2018, 9:45 am
**Overview** To work collaboratively within the IT organization to provide technical development/support for regulated applications supporting quality and R&D. **Responsibilities** + Working with a team comprised of business a...
Posted: January 20, 2018, 9:45 am
**Overview** Valeant Pharmaceuticals International, Inc. is a diverse pharmaceutical company that is committed to focusing on our key stakeholders while delivering consistently high performance. Our values provide the overall direction for ...
Posted: January 20, 2018, 9:45 am

Viewing page 1 of 55|Next Page

  Newsfeed | Subscribe  

Valeant Pharmaceuticals International Inc (NYSE:VRX) is trading with a trailing P/E of 5.6x, which is lower than the industry average of 24.2x. Although some investors may jump to the conclusion that this is a great buying opportunity, understandi...
Posted: January 19, 2018, 12:44 pm
LAVAL, Que. — Valeant Pharmaceuticals International Inc. says a U.S. District Court judge gave his preliminary approval Tuesday to a US$290-million settlement of lawsuits stemming from the unsuccessful attempted hostile takeover in 2014 of Botox m...
Posted: January 16, 2018, 8:43 pm
A federal judge signaled Tuesday he would approve a $290 million settlement reached by Pershing Square Capital Management, Valeant Pharmaceuticals International Inc. and the shareholders of Allergan PLC who had alleged the two firms improperly pro...
Posted: January 16, 2018, 7:02 pm
LAVAL, Quebec - Ortho Dermatologics, a division of Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) (' Valeant ') , today announced that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application for IDP-...
Posted: January 15, 2018, 7:28 am
Law360, New York (January 12, 2018, 9:18 PM EST) -- Valeant Pharmaceuticals has sued an AIG unit and other insurers, seeking coverage of its costs to defend lawsuits accusing it of orchestrating an insider trading scheme in connection with its att...
Posted: January 12, 2018, 7:51 pm

Viewing page 1 of 2|Next Page